Insider Selling: Cullinan Oncology, Inc. (NASDAQ:CGEM) CEO Sells $39,473.28 in Stock

Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) CEO Nadim Ahmed sold 4,272 shares of Cullinan Oncology stock in a transaction dated Tuesday, December 26th. The stock was sold at an average price of $9.24, for a total value of $39,473.28. Following the sale, the chief executive officer now directly owns 111,550 shares of the […]

Related Keywords

United States ,California ,Nadim Ahmed ,Cullinan Oncology Company Profile ,Nasdaq ,Securities Exchange Commission ,Nuveen Asset Management ,Cullinan Oncology Inc ,Pricet Rowe Associates Inc ,Cullinan Oncology ,Get Free Report ,Exchange Commission ,Asset Management ,State Teachers Retirement System ,Pricet Rowe Associates ,Cullinan Oncology Daily ,Nasdaq Cgem ,Cgem ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,